27.11.2023 14:40:23
|
Ocuphire Pharma Names Joseph Schachle COO
(RTTNews) - Ocuphire Pharma, Inc. (OCUP), an ophthalmic biopharmaceutical company, on Monday announced that it has appointed Joseph Schachle in its newly created role as chief operating officer, effective November 27.
Schachle most recently was the COO of Opus Genetics. He has also held senior positions in companies like Grifols, Parion Sciences and more.
In pre-market activity, Ocuphire shares are trading at $2.83, up 0.18% on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ocuphire Pharma Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Ocuphire Pharma Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Ocuphire Pharma Inc Registered Shs | 0,96 | -1,23% |
|